AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Assessment of Exercise Response in Chronic Fatigue Syndrome / Myalgic Encephalomyelitis.

Recruitingn/aAges 18 Years - 65 YearsAllEscuela Universitaria de Fisioterapia de la Once
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study evaluates the correlation between the 6-min walking test (6MWT) with gases measurement, and the peak cardiopulmonary exercise testing (CPET) using incremental cycling with gases and workload measurement, in order to determine if the 6MWT detects impairment in exercise tolerance and if it avoids the post-exertional malaise that the peak CPET causes on decreasing levels of physical activity, in participants affected by chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME). Physical activity level at baseline (usual activity, the parcipant will not be given any directions) will be recorded during 7 days, 24 hours/day. Afterwards, the 6MWT will be performed. After this test, the physical activity level will be collected again during 7 days, 24 hours/day. Peak CPET will be carried out 14 days after 6MWT to make sure that the basal levels are recovered, and finally, physical

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * To be diagnosed by a medical specialist in internal medicine with experience in this disease. For this, the participant must fulfill with the diagnostic criteria of CFS/ME, following the recommended criteria for the diagnosis of 2015. * Prior signing of the informed consent. Exclusion Criteria: * Present any of the diagnoses considered excluding of the CFS/ME, according to the international criteria recommended for clinical diagnosis and the selection of subjects for research: * Primary psychiatric disorders * Somatoform disorders * or Substance abuse * Present any of the absolute or relative contraindications, to perform exercise tests, described in previous investigations: * Decompensated heart failure * Acute myocardial infarction (less than 3 days) * Syncope * Unstable angina * Cardiac arrhythmia poorly controlled * Endocarditis, myocarditis or acute pericarditis * Acute pulmonary edema * Moderate or severe cardiac valvular stenosis * Suspected dissection or dissecting aortic aneurysm * O2 saturation at rest less than 85% * Acute renal failure * Untreated thyrotoxicosis * Acute infection * Uncontrolled hypertension (greater than 200-120 mmHg) * Hypertrophic obstructive cardiomyopathy * High-grade atrioventricular block * Significant pulmonary arterial hypertension * Advanced or risky pregnancy * Significant diselectrolithmia * Severe symptomatic aortic stenosis * Severe anemia * Pulmonary embolism * Acute thrombophlebitis * Traumatologic, orthopedic or neurological pathology that does not allow to walk or cycling. * Psychic incapacity to understand the instructions of the tests. * Present comorbidity of Multiple Chemical Sensitivity Syndrome. * Have performed the peak incremental CPET in the last 3 years.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Escuela Universitaria de Fisioterapia de la ONCE
Madrid, Spain
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy